Download pdf
Impact of Capital Structure on the Operating Performance of Listed Companies in the Pharmaceutical Industry
- 1 Capital University of Economics and Business
* Author to whom correspondence should be addressed.
Abstract
The objective of this paper is to explore the correlation between the capital structure and op-erating performance of selected leading pharmaceutical companies listed on the stock ex-change during the COVID-19 pandemic. To investigate how diverse capital structures influ-ence corporate performance, this study collects, calculates, and compares pertinent financial data, including leverage ratios, performance indicators, and cash flow, for these firms over three years. The findings show that companies with lower debt ratios are more likely to achieve stable earnings and cash flows, as well as to achieve higher performance indicators to some extent, compared to companies with higher debt ratios. Thus, capital structure has an impact on a company's operating performance. At the same time, a reasonable capital structure optimization can enhance a company's operating performance and mitigate opera-tional risks. It is recommended that listed companies in the pharmaceutical industry should focus on optimizing their capital structure to reduce financial risks and financing costs and to improve cash flow levels in order to achieve stable improvements in operating perfor-mance while ensuring sound operations and management. Investors should also focus on the capital structure of companies when making investment decisions and select those compa-nies with a sound capital structure for investment. These findings and recommendations provide suggestions and directions for the pharmaceutical industry to optimize its capital structure and improve its operating performance.
Keywords
capital structure, pharmaceutical industry, operating performance, financial risk, investor
[1]. Huang, G., Song, F. M.: The determinants of capital structure: evidence from China. China Economic Quarterly17(1), 14-36 (2006).
[2]. Guo, P. F., Sun, P. Y.: Industry characteristics of capital structure: An empirical study based on Chinese listed companies. Economic Research Journal (05),66-73+93 (2003).
[3]. Eriotis, N., Vasiliou, D., Ventoura-Neokosmidi, Z.: How firm characteristics affect capital structure: an empirical study. Managerial Finance, 33(5), 321-331(2007).
[4]. Ria, R.: Determinant Factors of Corporate Governance on Company Performance: Mediating Role of Capital Structure. Sustainability, 15(3), 2309(2023).
[5]. Campello, M.: Capital structure and product markets interactions: evidence from business cycles. Journal of Financial Economics, 68(3), 353-378 (2000).
[6]. Eli, Ofek.: Capital structure and firm response to poor performance: an empirical analysis. Journal of Financial Economics(1993).
[7]. Hu, P. P.: A study on the correlation between capital structure and operating performance of companies listed on GEM(D). (2015). Harbin University of Science and Technology.
[8]. Li, D. N.: A study on the interaction between capital structure and corporate performance of companies listed on GEM(D). (2013). Dongbei University Of Finance And Economics.
[9]. Zhang, W. Y.: Impact of capital structure on profitability of listed companies in the pharmaceutical manufacturing industry. CO-Operative economy & Science (14),132-134 (2021).
[10]. Deng, X. L., Wang, Z. J., Luo, J. W., Xia, T.: An empirical analysis of the capital structure of listed companies in China's pharmaceutical industry. Finance and Trade Research (02),97-103(2005).
Cite this article
Chen,L. (2023). Impact of Capital Structure on the Operating Performance of Listed Companies in the Pharmaceutical Industry. Advances in Economics, Management and Political Sciences,40,61-67.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 7th International Conference on Economic Management and Green Development
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).